Increased RhoA/ROK mRNA expression and function in diabetic vein grafts compared with nondiabetic vein grafts and diabetic arterial grafts

Thoracic and Cardiovascular Surgeon

Volumn 58, Issue 3, 2010, Pages 148-153

  Ding, R ^a   Hu, D Y ^a   Xia, K ^b   Yang, X C ^b  

^a PEKING UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Coronary bypass surgery; Heart disease; Myocardial infarction

Indexed keywords

FASUDIL; PHENYLEPHRINE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGED; ARTERY GRAFT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GENE EXPRESSION; GRAFT PATENCY; HEART CONTRACTION; HEART MUSCLE RELAXATION; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; VEIN GRAFT;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADULT; AGED; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY ARTERIES; MIDDLE AGED; PHENYLEPHRINE; PROTEIN KINASE INHIBITORS; RADIAL ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; RNA, MESSENGER; SAPHENOUS VEIN; VASCULAR PATENCY; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 77950826165     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0029-1186267     Document Type: Article

References (24)

1. Kandabashi T, Shimokawa H, Mukai Y, Matoba T, Kunihiro I, Morikawa K, Ito M, Takahashi S, Kaibuchi K, Takeshita A. Involvement of Rho-kinase agonists-induced contraction of arteriosclerotic human arteries. Arterioscler Thromb Vasc Riol 2002 22 243-248 (Pubitemid 34127034)
2. Crowley C M., Lee C H., Gin S A., Keep A M., Cook R C., Breemen C V. The mechanism of excitation-contraction coupling in phenylephrine-stimulated human saphenous vein. Am J Physiol Heart Circ Physiol 2002 283 H1271-H1281
3. Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao J K. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 2002 106 57-62 (Pubitemid 34747442)
4. Laufs U, Marra D, Node K, Liao J K. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(KiP1). J Biol Chem 1999 274 21926-21931 (Pubitemid 129519746)
5. Seasholtz T M., Zhang T, Morissette M R., Howes A L., Yang A H., Brown J H. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip 1) expression in the vasculature of hypertensive rats. Circ Re 2001 89 488-495 (Pubitemid 34132642)
6. Chaulet H, Desgranges C, Renault M A., Dupuch F, Ezan G, Peiretti F, Loirand G, Pacaud P, Gadeau A P. Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res 2001 89 904-914
7. Mack C P., Somlyo A V., Hautmann M, Somlyo A P., Owens G K. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 2001 276 341-347 (Pubitemid 32050325)
8. Laufs U, La Fata V, Plutzky J, Liao J K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998 97 1129-1135 (Pubitemid 28152885)
9. Miao L, Calvert J W., Tang J, Parent A D., Zhang J H. Upregulation of small GTPase RhoA in the basilar artery from diabetic (mellitus) rats. Life Sci 2002 71 1175-1185 (Pubitemid 34727356)
10. Hattori T, Shimokawa H, Higashi M, Hiroki J, Mukai Y, Kaibuchi K, Takeshita A. Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice. Circ Res 2004 94 46-52 (Pubitemid 38064097)
11. Gaudino M, Luciani N, Nasso G, Salica A, Canosa C, Possati G. Is postoperative calcium channel blocker therapy needed in patients with radial artery grafts? J Thorac Cardiovasc Surg 2005 129 532-535 (Pubitemid 40311311)
12. Shapira O M., Xu A, Vita J A., Aldea G S., Shah N, Shemin R J., Keaney Jr J F. Nitroglycerin is superior to diltizaem as a coronary bypass conduit vasodilator. J Thorac Cardiovasc Surg 1999 117 906-911 (Pubitemid 29210773)
13. Hisaoka T, Yano M, Ohkusa T, Suetsugu M, Ono K, Kohno M, Yamada J, Kobayashi S, Kohno M, Matsuzaki M. Enhancement of Rho/Rho kinase system in regulation of vascular smooth muscle contraction in tachycardial induced heart failure. Cardiovascular Res 2001 49 319-329 (Pubitemid 32119549)
14. Didion S P., Lynch C M., Baumbach G L., Faraci F M. Impaired endothelium-dependent responses and enhanced influence of Rho-kinase in cerebral arterioles in type II diabetes. Stroke 2005 36 342-347
15. Lorusso R, Pentiricci S, Raddino R, Scarabelli T M., Zambelli C, Villanacci V, Burattin A, Romanelli G, Casari S, Scelsi R, Giustina A. Influence of type 2 diabetes on functional and structure properties of coronary artery bypass conduits. Diabetes 2003 52 2814-2820 (Pubitemid 37339712)
16. Gohla A, Schultz G, Offermanns S. Role for G12/G13 in agonist-induced vascular smooth muscle cell contraction. Circ Res 2000 87 221-227
17. Sauzeau V, le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann S M., Bertoglio J et al. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 2000 275 21722-21729
18. Gudi T, Chen J C., Casteel D E., Seasholtz T M., Boss G R., Pilz R B. CGMP-dependent protein kinase inhibitors serum-response element-dependent transcription by inhibiting Rho activation and function. J Biol Chem 2002 277 37382-37393
19. Akiyama N, Naruse K, Kobayashi Y, Nakamura N, Hamada Y, Nakashima E, Matsubara T, Oiso Y, Nakamura J. High glucose-induced upregulation of Rho/Rho-kinase via platelet-derived growth factor receptor-beta increases migration of aortic smooth muscle cells. J Mol Cell Cardiol 2008 45 (2) 326-332
20. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 1992 76 571-577
21. Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H, Katagiri T, Yamauchi K, Yui Y, Minamino T, Nakashima M, Kato K. Antianginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 2002 39 319-327
22. Gaudino M, Luciani N, Nasso G, Salica A, Canosa C, Possati G. Is postoperative calcium channel blocker therapy needed in patients with radial artery grafts? J Thorac Cardiovasc Surg 2005 129 532-535 (Pubitemid 40311311)
23. Vicari R M., Smith W B., Chaitman B, Chrysant S G., Tonkon M J., Bitter N, Weiss R J., Thadani U. A randomized, double-blind, placebo-controlled, phase 2 study: the efficacy of fasudil in patients with stable angina. Eur Heart J 2004 25 138
24. Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H, Hafezi-Moghadam A, Ishibashi T. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes 2009 58 (1) 215-226